Critical role for ERK1/2 in bone marrow and fetal liver–derived primary megakaryocyte differentiation, motility, and proplatelet formation

Objective Megakaryopoiesis and platelet formation is a multistep process through which hematopoietic progenitor cells develop into mature megakaryocytes (MKs) and form proplatelets. The present study investigates the regulation of different steps of megakaryopoiesis (i.e., differentiation, migration, and proplatelet formation) by extracellar signal-regulated kinase (ERK)1/2 and p38 mitogen-activated protein kinase (MAPK) in two models of primary murine MKs derived from bone marrow (BM) cells and fetal liver (FL) cells. Materials and Methods A preparation of MKs was generated from BM obtained from femora and tibiae of C57BL6 mice. FL-derived MKs were obtained from the liver of mouse fetuses aged 13 to 15 days. Results For both cell populations, activation of MEK-ERK1/2 pathway by thrombopoietin was found to have a critical role in MK differentiation, regulating polyploidy and surface expression of CD34, GPIIb, and GPIb. The MEK-ERK1/2 pathway plays a major role in migration of BM-derived MKs toward a stromal-cell−derived factor 1α (SDF1α) gradient, whereas unexpectedly, FL-derived cells fail to migrate in response to the chemokine due to negligible expression of its receptor, CXCR4. The MEK-ERK1/2 pathway also plays a critical role in the generation of proplatelets. In contrast, p38MAPK pathway was not involved in any of these processes. Conclusion This report demonstrates a critical role of MEK-ERK1/2 pathway in MK differentiation, motility, and proplatelet formation. This study highlights several differences between BM- and FL-derived MKs, which are discussed.

[1]  T. Sturgill,et al.  Insulin-stimulated microtubule associated protein kinase is detectable by analytical gel chromatography as a 35-kDa protein in myocytes, adipocytes, and hepatocytes. , 1988, Archives of biochemistry and biophysics.

[2]  K. Ravid,et al.  Polyploidy: occurrence in nature, mechanisms, and significance for the megakaryocyte-platelet system. , 2000, Experimental hematology.

[3]  D. Goeddel,et al.  Stimulation of megakaryocytopoiesis and thrombopoiesis by the c-Mpl ligand , 1994, Nature.

[4]  Niels Galjart,et al.  Differential roles of microtubule assembly and sliding in proplatelet formation by megakaryocytes. , 2005, Blood.

[5]  Y. Sonoda,et al.  Simultaneous signalling through c‐mpl, c‐kit and CXCR4 enhances the proliferation and differentiation of human megakaryocyte progenitors: possible roles of the PI3‐K, PKC and MAPK pathways , 2001, British journal of haematology.

[6]  C. Peschle,et al.  Inhibition of TPO-induced MEK or mTOR activity induces opposite effects on the ploidy of human differentiating megakaryocytes , 2006, Journal of Cell Science.

[7]  W. Sheridan,et al.  Biology of thrombopoiesis and the role of Mpl ligand in the production and function of platelets. , 1997, Platelets.

[8]  F. Porteu,et al.  Megakaryocyte Growth and Development Factor-Induced Proliferation and Differentiation Are Regulated by the Mitogen-Activated Protein Kinase Pathway in Primitive Cord Blood Hematopoietic Progenitors , 1999 .

[9]  T. Vik,et al.  Activation of the mitogen-activated protein kinase pathway is involved in and sufficient for megakaryocytic differentiation of CMK cells. , 1997, Blood.

[10]  M. Karjalainen‐Lindsberg,et al.  AP-1 regulates α2β1 integrin expression by ERK-dependent signals during megakaryocytic differentiation of K562 cells , 2005 .

[11]  R. Shivdasani,et al.  Characterization of the Hematopoietic Transcription Factor NF-E2 in Primary Murine Megakaryocytes* , 1998, The Journal of Biological Chemistry.

[12]  S. Rafii,et al.  The Regulation of Hematopoietic Stem Cell and Progenitor Mobilization by Chemokine SDF-1 , 2003, Leukemia & lymphoma.

[13]  R. Shivdasani,et al.  Mechanisms of thrombopoiesis , 2005, Journal of thrombosis and haemostasis : JTH.

[14]  V. Deutsch,et al.  Megakaryocyte development and platelet production , 2006, British journal of haematology.

[15]  V. Broudy,et al.  Thrombopoietin, the Mp1 ligand, is essential for full megakaryocyte development. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[16]  D. Lannigan,et al.  Structural basis for the activity of the RSK-specific inhibitor, SL0101. , 2007, Bioorganic & medicinal chemistry.

[17]  David A. Cheresh,et al.  Regulation of Cell Motility by Mitogen-activated Protein Kinase , 1997, The Journal of cell biology.

[18]  S. Watson,et al.  Direct Inhibition of Cyclooxygenase-1 and -2 by the Kinase Inhibitors SB 203580 and PD 98059 , 1998, The Journal of Biological Chemistry.

[19]  R. Herrera,et al.  A role for the MEK/MAPK pathway in PMA-induced cell cycle arrest: modulation of megakaryocytic differentiation of K562 cells. , 1998, Experimental cell research.

[20]  Donna J. Webb,et al.  FAK–Src signalling through paxillin, ERK and MLCK regulates adhesion disassembly , 2004, Nature Cell Biology.

[21]  P. Auberger,et al.  A survey of the signaling pathways involved in megakaryocytic differentiation of the human K562 leukemia cell line by molecular and c-DNA array analysis , 2006, Oncogene.

[22]  F. Tablin,et al.  Blood platelet formation in vitro. The role of the cytoskeleton in megakaryocyte fragmentation. , 1990, Journal of cell science.

[23]  R. Klemke,et al.  Regulation of Cell Contraction and Membrane Ruffling by Distinct Signals in Migratory Cells , 1999, The Journal of cell biology.

[24]  N. Ahn,et al.  Megakaryocytic differentiation induced by constitutive activation of mitogen-activated protein kinase kinase , 1997, Molecular and cellular biology.

[25]  E. Vellenga,et al.  Downregulation of Signal Transducer and Activator of Transcription 5 (STAT5) in CD34+ Cells Promotes Megakaryocytic Development, Whereas Activation of STAT5 Drives Erythropoiesis , 2008, Stem cells.

[26]  A. Wickrema,et al.  Erythroid and megakaryocytic transformation , 2007, Oncogene.

[27]  J. Maller,et al.  Insulin-stimulated MAP-2 kinase phosphorylates and activates ribosomal protein S6 kinase II , 1988, Nature.

[28]  Yohnosuke Kobayashi,et al.  Requirement of thrombopoietin-induced activation of ERK for megakaryocyte differentiation and of p38 for erythroid differentiation , 2001, Annals of Hematology.

[29]  S. Watson,et al.  Regulation of proplatelet formation and platelet release by integrin αIIbβ3 , 2006 .

[30]  Scott R. Presnell,et al.  Cloning and expression of murine thrombopoietin cDNA and stimulation of platelet production in vivo , 1994, Nature.

[31]  Wei Chen,et al.  Differential regulation and properties of MAPKs , 2007, Oncogene.

[32]  S. Goueli,et al.  Sustained Activation of the Extracellular Signal-regulated Kinase/Mitogen-activated Protein Kinase Pathway Is Required for Megakaryocytic Differentiation of K562 Cells* , 1997, The Journal of Biological Chemistry.

[33]  L. Amos,et al.  Microtubules and maps. , 2005, Advances in protein chemistry.

[34]  Thrombopoietin-induced activation of the mitogen-activated protein kinase (MAPK) pathway in normal megakaryocytes: role in endomitosis. , 1999 .

[35]  S. Watson,et al.  A novel role for PECAM-1 in megakaryocytokinesis and recovery of platelet counts in thrombocytopenic mice. , 2007, Blood.

[36]  S. Nilsson,et al.  Immunofluorescence Characterization of Key Extracellular Matrix Proteins in Murine Bone Marrow In Situ , 1998, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[37]  J. Hartwig,et al.  Blood Platelets Are Assembled Principally at the Ends of Proplatelet Processes Produced by Differentiated Megakaryocytes , 1999, The Journal of cell biology.

[38]  N. Komatsu,et al.  Thrombopoietin induces tyrosine phosphorylation and activation of mitogen-activated protein kinases in a human thrombopoietin-dependent cell line. , 1995, Biochemical and biophysical research communications.

[39]  K. Takenaka,et al.  Development of ET, primary myelofibrosis and PV in mice expressing JAK2 V617F , 2008, Leukemia.

[40]  Yuzhi Jia,et al.  Fibronectin- and protein kinase C-mediated activation of ERK/MAPK are essential for proplateletlike formation. , 2002, Blood.

[41]  I. Dusanter-Fourt,et al.  Control of thrombopoietin-induced megakaryocytic differentiation by the mitogen-activated protein kinase pathway , 1997, Molecular and cellular biology.

[42]  W. Vainchenker,et al.  Thrombopoietin and its receptor. , 1998, European cytokine network.

[43]  J. Griffin,et al.  The c-Mpl Ligand (Thrombopoietin) Stimulates Tyrosine Phosphorylation of Jak2, Shc, and c-Mpl (*) , 1995, The Journal of Biological Chemistry.

[44]  C. Peschle,et al.  Stromal cell-derived factor 1alpha increases polyploidization of megakaryocytes generated by human hematopoietic progenitor cells. , 2001, Blood.

[45]  B. Göttgens,et al.  Differentiation of murine committed megakaryocytic progenitors isolated by a novel strategy reveals the complexity of GATA and Ets factor involvement in megakaryocytopoiesis and an unexpected potential role for GATA-6. , 2006, Experimental hematology.

[46]  K. Kaushansky,et al.  Actin reorganization and proplatelet formation in murine megakaryocytes: the role of protein kinase calpha. , 2001, Blood.

[47]  R. Bodnar,et al.  Epidermal Growth Factor Activates m-Calpain (Calpain II), at Least in Part, by Extracellular Signal-Regulated Kinase-Mediated Phosphorylation , 2004, Molecular and Cellular Biology.